|
Press Releases |
|
|
|
Monday, December 4, 2023 |
|
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China |
more info >> |
|
Thursday, August 24, 2023 |
|
China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug |
more info >> |
|
China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug |
more info >> |
|
Monday, July 31, 2023 |
|
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management |
Recently, MSCI (Morgan Stanley Capital International), the world's largest index company, announced the latest Environmental, Social, and Governance (ESG) evaluation report for China Medical System Holdings limited ("CMS" or the "Group"), who achieved an "AA" rating and surpassed 75% of global peers with leading ESG management practices. more info >> |
|
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management |
Recently, MSCI (Morgan Stanley Capital International), the world's largest index company, announced the latest Environmental, Social, and Governance (ESG) evaluation report for China Medical System Holdings limited ("CMS" or the "Group"), who achieved an "AA" rating and surpassed 75% of global peers with leading ESG management practices. more info >> |
|
Thursday, June 29, 2023 |
|
China Medical System Included in the First 'Sustainability Yearbook (China)' of S&P Global |
more info >> |
|
Monday, June 12, 2023 |
|
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China |
more info >> |
|
China Medical System: The first 'Diazepam Nasal Spray' Approved for Marketing in China |
more info >> |
|
Tuesday, May 30, 2023 |
|
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China |
On May 30, China Medical System Holdings Limited ("CMS" or the "Group") announced that on 26 May 2023, the New Drug Application (NDA) of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China (NMPA). ILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. more info >> |
|
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China |
On May 30, China Medical System Holdings Limited ("CMS" or the "Group") announced that on 26 May 2023, the New Drug Application (NDA) of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China (NMPA). ILUMETRI is indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Prestigious titles for top developers at the 14th PropertyGuru Asia Property Awards (Singapore)
Apr 19, 2024 11:30 HKT/SGT
|
|
|
朝雲集團(06601.HK):穩健增長與高派息策略共驅,多家頭部券商給予增持評級
Apr 19, 2024 10:24 HKT/SGT
|
|
|
22nd Edition of Cyber Security Summit: Thailand to Convene Esteemed Panel of Industry Leaders
Apr 19, 2024 10:11 HKT/SGT
|
|
|
The Rapidly Evolving Real Estate Landscape: Redefine Real Estate Summit Connects Key Players in South East Asia
Apr 19, 2024 10:11 HKT/SGT
|
|
|
富士通、世界初 形式の異なる企業のデジタルアイデンティティー証明書を変換する技術を開発し欧州データスペースへの接続実証に成功
Apr 19, 2024 10:00: JST
|
|
|
Eesee Implements Blockpass for Compliance in Digital Assets Marketplace
Apr 19, 2024 10:00 HKT/SGT
|
|
|
Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces
Apr 19, 2024 10:17 JST
|
|
|
Rapid Evolution in Philippines' BFSI Sector: BFSI IT Summit 2024 to Illuminate Transformation
Apr 19, 2024 08:02 HKT/SGT
|
|
|
GLOBE LIFE (GL): Kaplan Fox & Kilsheimer LLP Investigates GLOBE LIFE and Encourages Investors to Contact the Firm
Apr 19, 2024 08:00 HKT/SGT
|
|
|
标题:巨星传奇:2023年IP业务收入同比增长82.9%
Apr 18, 2024 21:19 HKT/SGT
|
|
|
標題:巨星傳奇:2023年IP業務收入同比增長82.9%
Apr 18, 2024 21:17 HKT/SGT
|
|
|
e& life joins Dubai FinTech Summit as a Powered By sponsor
Apr 18, 2024 20:56 HKT/SGT
|
|
|
DC Healthcare Rides the Wave of Success with New Openings at Publika and Bukit Indah
Apr 18, 2024 19:33 HKT/SGT
|
|
|
Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas
Apr 18, 2024 17:01 JST
|
|
|
Crown Digital Spearheads the Future of AI in F&B with Ella the Robobarista at AIM Global
Apr 18, 2024 16:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|